dihydroxyphenylalanine has been researched along with Anxiety Disorders in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, JO | 1 |
| Almici, GM | 1 |
| Sbarbaro, V | 1 |
2 other studies available for dihydroxyphenylalanine and Anxiety Disorders
| Article | Year |
|---|---|
The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
Topics: Antidepressive Agents; Anxiety Disorders; Attitude of Health Personnel; Behavior Therapy; Brain; Con | 1972 |
[Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
Topics: Aged; Anxiety Disorders; Cognition Disorders; Depression; Dihydroxyphenylalanine; Female; Hallucinat | 1974 |